Sep 09, 2019 / 12:45PM GMT
Rivka Regina Goldwasser - Morgan Stanley, Research Division - MD
So good morning, everybody. I'm Ricky Goldwasser. I'm Morgan Stanley's health care services analyst. And I have a very big note here that says that I should read this, these disclosures before every session. So please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at www.morganstanley.com, Research Disclosure or at the registration desk if you're interested in reading it.
And with that, I'm very pleased to have the Catalent management team here with me this morning. To my left are Catalent's CEO, John Chiminski; and CFO, Wetteny Joseph.
2019 was a big year for Catalent. You did a series of acquisitions that expanded your positioning and role in the biologic marketplace and really repositioned the company to be a key player in this growing market and also really raised your growth profile
So with that, John, how about I'll hand it off for you
Catalent Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers